1
|
Pedrana A, Bowring A, Heath K, Thomas AJ, Wilkinson A, Fletcher-Lartey S, Saich F, Munari S, Oliver J, Merner B, Altermatt A, Nguyen T, Nguyen L, Young K, Kerr P, Osborne D, Kwong EJL, Corona MV, Ke T, Zhang Y, Eisa L, Al-Qassas A, Malith D, Davis A, Gibbs L, Block K, Horyniak D, Wallace J, Power R, Vadasz D, Ryan R, Shearer F, Homer C, Collie A, Meagher N, Danchin M, Kaufman J, Wang P, Hassani A, Sadewo GRP, Robins G, Gallagher C, Matous P, Roden B, Karkavandi MA, Coutinho J, Broccatelli C, Koskinen J, Curtis S, Doyle JS, Geard N, Hill S, Coelho A, Scott N, Lusher D, Stoové MA, Gibney KB, Hellard M. Priority populations' experiences of isolation, quarantine and distancing for COVID-19: protocol for a longitudinal cohort study (Optimise Study). BMJ Open 2024; 14:e076907. [PMID: 38216183 PMCID: PMC10806709 DOI: 10.1136/bmjopen-2023-076907] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 06/20/2023] [Accepted: 12/04/2023] [Indexed: 01/14/2024] Open
Abstract
INTRODUCTION Longitudinal studies can provide timely and accurate information to evaluate and inform COVID-19 control and mitigation strategies and future pandemic preparedness. The Optimise Study is a multidisciplinary research platform established in the Australian state of Victoria in September 2020 to collect epidemiological, social, psychological and behavioural data from priority populations. It aims to understand changing public attitudes, behaviours and experiences of COVID-19 and inform epidemic modelling and support responsive government policy. METHODS AND ANALYSIS This protocol paper describes the data collection procedures for the Optimise Study, an ongoing longitudinal cohort of ~1000 Victorian adults and their social networks. Participants are recruited using snowball sampling with a set of seeds and two waves of snowball recruitment. Seeds are purposively selected from priority groups, including recent COVID-19 cases and close contacts and people at heightened risk of infection and/or adverse outcomes of COVID-19 infection and/or public health measures. Participants complete a schedule of monthly quantitative surveys and daily diaries for up to 24 months, plus additional surveys annually for up to 48 months. Cohort participants are recruited for qualitative interviews at key time points to enable in-depth exploration of people's lived experiences. Separately, community representatives are invited to participate in community engagement groups, which review and interpret research findings to inform policy and practice recommendations. ETHICS AND DISSEMINATION The Optimise longitudinal cohort and qualitative interviews are approved by the Alfred Hospital Human Research Ethics Committee (# 333/20). The Optimise Study CEG is approved by the La Trobe University Human Ethics Committee (# HEC20532). All participants provide informed verbal consent to enter the cohort, with additional consent provided prior to any of the sub studies. Study findings will be disseminated through public website (https://optimisecovid.com.au/study-findings/) and through peer-reviewed publications. TRIAL REGISTRATION NUMBER NCT05323799.
Collapse
Affiliation(s)
- Alisa Pedrana
- Burnet Institute, Melbourne, Victoria, Australia
- School of Public Health and Preventive Medicine, Monash University, Melbourne, Victoria, Australia
| | - Anna Bowring
- Burnet Institute, Melbourne, Victoria, Australia
| | | | | | - Anna Wilkinson
- Burnet Institute, Melbourne, Victoria, Australia
- School of Public Health and Preventive Medicine, Monash University, Melbourne, Victoria, Australia
| | | | - Freya Saich
- Burnet Institute, Melbourne, Victoria, Australia
| | | | - Jane Oliver
- Department of Infectious Diseases, The Peter Doherty Institute for Infection and Immunity, Melbourne, Victoria, Australia
| | - Bronwen Merner
- Centre for Health Communication and Participation, La Trobe University, Melbourne, Victoria, Australia
| | | | - Thi Nguyen
- Burnet Institute, Melbourne, Victoria, Australia
| | - Long Nguyen
- Burnet Institute, Melbourne, Victoria, Australia
| | | | - Phoebe Kerr
- Burnet Institute, Melbourne, Victoria, Australia
| | | | | | - Martha Vazquez Corona
- Melbourne School of Population and Global Health, The University of Melbourne, Melbourne, Victoria, Australia
| | - Tianhui Ke
- Burnet Institute, Melbourne, Victoria, Australia
| | - Yanqin Zhang
- Burnet Institute, Melbourne, Victoria, Australia
| | - Limya Eisa
- Burnet Institute, Melbourne, Victoria, Australia
| | | | - Deng Malith
- Burnet Institute, Melbourne, Victoria, Australia
| | - Angela Davis
- Burnet Institute, Melbourne, Victoria, Australia
| | - Lisa Gibbs
- Melbourne School of Population and Global Health, The University of Melbourne, Melbourne, Victoria, Australia
- Centre for Disaster Management and Public Safety, The University of Melbourne, Melbourne, Victoria, Australia
| | - Karen Block
- Melbourne School of Population and Global Health, The University of Melbourne, Melbourne, Victoria, Australia
| | - Danielle Horyniak
- Burnet Institute, Melbourne, Victoria, Australia
- School of Public Health and Preventive Medicine, Monash University, Melbourne, Victoria, Australia
| | - Jack Wallace
- Burnet Institute, Melbourne, Victoria, Australia
| | - Robert Power
- Burnet Institute, Melbourne, Victoria, Australia
- School of Public Health and Preventive Medicine, Monash University, Melbourne, Victoria, Australia
| | - Danny Vadasz
- Health Issues Centre, Melbourne, Victoria, Australia
| | - Rebecca Ryan
- Centre for Health Communication and Participation, La Trobe University, Melbourne, Victoria, Australia
| | - Freya Shearer
- Centre for Epidemiology and Biostatistics, Melbourne School of Population and Global Health, The University of Melbourne, Melbourne, Victoria, Australia
| | | | - Alex Collie
- School of Public Health and Preventive Medicine, Monash University, Melbourne, Victoria, Australia
| | - Niamh Meagher
- Department of Infectious Diseases, The Peter Doherty Institute for Infection and Immunity, Melbourne, Victoria, Australia
| | - Margaret Danchin
- Murdoch Childrens Research Institute, Parkville, Victoria, Australia
- Department of Paediatrics, The University of Melbourne, Melbourne, Victoria, Australia
| | - Jessica Kaufman
- Murdoch Childrens Research Institute, Parkville, Victoria, Australia
| | - Peng Wang
- School of Business, Law and Entrepreneurship, Swinburne University of Technology, Hawthorn, Victoria, Australia
- SNA Toolbox, Melbourne, Victoria, Australia
| | | | | | - Garry Robins
- Melbourne School of Psychological Sciences, The University of Melbourne, Melbourne, Victoria, Australia
| | - Colin Gallagher
- Melbourne School of Population and Global Health, The University of Melbourne, Melbourne, Victoria, Australia
| | - Petr Matous
- The University of Sydney Faculty of Engineering and Information Technologies, Sydney, New South Wales, Australia
| | - Bopha Roden
- School of Business, Law and Entrepreneurship, Swinburne University of Technology, Hawthorn, Victoria, Australia
| | | | - James Coutinho
- School of Business, Law and Entrepreneurship, Swinburne University of Technology, Hawthorn, Victoria, Australia
| | - Chiara Broccatelli
- Institute for Social Science Research, The University of Queensland, Saint Lucia, Queensland, Australia
| | - Johan Koskinen
- Melbourne School of Psychological Sciences, The University of Melbourne, Melbourne, Victoria, Australia
- Department of Statistics, Stockholm University, Stockholm, Sweden
| | - Stephanie Curtis
- Burnet Institute, Melbourne, Victoria, Australia
- Department of Infectious Diseases, Monash University, Clayton, Victoria, Australia
| | - Joseph S Doyle
- Burnet Institute, Melbourne, Victoria, Australia
- Department of Infectious Diseases, Monash University, Clayton, Victoria, Australia
| | - Nicholas Geard
- School of Computing & Information Systems, The University of Melbourne, Melbourne, Victoria, Australia
| | - Sophie Hill
- Centre for Health Communication and Participation, La Trobe University, Melbourne, Victoria, Australia
| | | | - Nick Scott
- Burnet Institute, Melbourne, Victoria, Australia
- School of Public Health and Preventive Medicine, Monash University, Melbourne, Victoria, Australia
| | - Dean Lusher
- School of Business, Law and Entrepreneurship, Swinburne University of Technology, Hawthorn, Victoria, Australia
- SNA Toolbox, Melbourne, Victoria, Australia
| | - Mark A Stoové
- Burnet Institute, Melbourne, Victoria, Australia
- School of Public Health and Preventive Medicine, Monash University, Melbourne, Victoria, Australia
| | - Katherine B Gibney
- Department of Infectious Diseases, The Peter Doherty Institute for Infection and Immunity, Melbourne, Victoria, Australia
| | - Margaret Hellard
- Burnet Institute, Melbourne, Victoria, Australia
- School of Public Health and Preventive Medicine, Monash University, Melbourne, Victoria, Australia
| |
Collapse
|
3
|
Gibbs L, Thomas AJ, Coelho A, Al-Qassas A, Block K, Meagher N, Eisa L, Fletcher-Lartey S, Ke T, Kerr P, Kwong EJL, MacDougall C, Malith D, Marinkovic Chavez K, Osborne D, Price DJ, Shearer F, Stoove M, Young K, Zhang Y, Gibney KB, Hellard M. Inclusion of Cultural and Linguistic Diversity in COVID-19 Public Health Research: Research Design Adaptations to Seek Different Perspectives in Victoria, Australia. INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTH 2023; 20:2320. [PMID: 36767686 PMCID: PMC9916203 DOI: 10.3390/ijerph20032320] [Citation(s) in RCA: 1] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Figures] [Subscribe] [Scholar Register] [Received: 11/24/2022] [Revised: 01/17/2023] [Accepted: 01/21/2023] [Indexed: 06/18/2023]
Abstract
Participation of people from culturally and linguistically diverse (CALD) communities in public health research is often limited by challenges with recruitment, retention and second-language data collection. Consequently, people from CALD communities are at risk of their needs being marginalised in public health interventions. This paper presents intrinsic case analyses of two studies which were adapted to increase the cultural competence of research processes. Both cases were part of the Optimise study, a major mixed methods research study in Australia which provided evidence to inform the Victorian state government's decision-making about COVID-19 public health measures. Case study 1 involved the core Optimise longitudinal cohort study and Case study 2 was the CARE Victorian representative survey, an Optimise sub-study. Both case studies engaged cultural advisors and bilingual staff to adjust the survey measures and research processes to suit target CALD communities. Reflexive processes provided insights into the strengths and weaknesses of the inclusive strategies. Selected survey results are provided, demonstrating variation across CALD communities and in comparison to participants who reported speaking English at home. While in most cases a gradient of disadvantage was evident for CALD communities, some patterns were unexpected. The case studies demonstrate the challenge and value of investing in culturally competent research processes to ensure research guiding policy captures a spectrum of experiences and perspectives.
Collapse
Affiliation(s)
- Lisa Gibbs
- Melbourne School of Population and Global Health, The University of Melbourne, Carlton, VIC 3053, Australia
| | | | | | | | - Karen Block
- Melbourne School of Population and Global Health, The University of Melbourne, Carlton, VIC 3053, Australia
| | - Niamh Meagher
- Peter Doherty Institute for Infection & Immunity, The University of Melbourne, Parkville, VIC 3052, Australia
| | - Limya Eisa
- The Burnet Institute, Melbourne, VIC 3004, Australia
| | | | - Tianhui Ke
- The Burnet Institute, Melbourne, VIC 3004, Australia
| | - Phoebe Kerr
- The Burnet Institute, Melbourne, VIC 3004, Australia
| | - Edwin Jit Leung Kwong
- Melbourne School of Population and Global Health, The University of Melbourne, Carlton, VIC 3053, Australia
| | - Colin MacDougall
- Melbourne School of Population and Global Health, The University of Melbourne, Carlton, VIC 3053, Australia
| | - Deng Malith
- The Burnet Institute, Melbourne, VIC 3004, Australia
| | - Katitza Marinkovic Chavez
- Melbourne School of Population and Global Health, The University of Melbourne, Carlton, VIC 3053, Australia
| | | | - David J. Price
- Melbourne School of Population and Global Health, The University of Melbourne, Carlton, VIC 3053, Australia
- Peter Doherty Institute for Infection & Immunity, The University of Melbourne, Parkville, VIC 3052, Australia
| | - Freya Shearer
- Melbourne School of Population and Global Health, The University of Melbourne, Carlton, VIC 3053, Australia
| | - Mark Stoove
- The Burnet Institute, Melbourne, VIC 3004, Australia
- School of Public Health and Preventive Medicine, Monash University, Melbourne, VIC 3004, Australia
- Australian Research Centre in Sex, Health and Society, La Trobe University, Bundoora, VIC 3083, Australia
| | - Kathryn Young
- The Burnet Institute, Melbourne, VIC 3004, Australia
| | - Yanqin Zhang
- The Burnet Institute, Melbourne, VIC 3004, Australia
| | - Katherine B. Gibney
- Peter Doherty Institute for Infection & Immunity, The University of Melbourne, Parkville, VIC 3052, Australia
| | | |
Collapse
|
4
|
Moghnieh R, El Hajj C, Abdallah D, Jbeily N, Bizri AR, Sayegh MH. Immunogenicity and Effectiveness of Primary and Booster Vaccine Combination Strategies during Periods of SARS-CoV-2 Delta and Omicron Variants. Vaccines (Basel) 2022; 10:1596. [PMID: 36298460 PMCID: PMC9607825 DOI: 10.3390/vaccines10101596] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/17/2022] [Revised: 09/12/2022] [Accepted: 09/16/2022] [Indexed: 11/22/2022] Open
Abstract
In this study involving a cohort of employees of the National Airline company in Lebanon, we assessed humoral immunity levels and the effectiveness of two COVID-19 vaccines, Gam-COVID-Vac versus BNT162b2, after two doses and after a homologous and heterologous BNT162b2 booster, in addition to the impact of hybrid immunity. Vaccine effectiveness (VE) was retrospectively determined against laboratory-confirmed SARS-CoV-2 infection during the periods of Delta and Omicron variants' predominance, separately, and was calculated based on a case-control study design. The humoral immune response, measured by a SARS-CoV-2 anti-spike receptor-binding domain (RBD) IgG titer, was prospectively assessed after the aforementioned vaccination schemes at different time points. This study showed higher effectiveness of BNT162b2 after two doses (81%) compared to two doses of Gam-COVID-Vac (41.8%) against the Delta variant of SARS-CoV-2, which correlated with anti-spike antibody levels. Regarding the Omicron variant, protection against infection and antibody levels were severely compromised and the correlation between an anti-spike IgG titer and effectiveness was lost, unlike the situation during the Delta wave. Considering the booster vaccination schemes, a homologous BNT162b2 booster after a BNT162b2 primary vaccination induced a higher humoral immune response when compared to that induced by a heterologous BNT162b2 booster after a Gam-COVID-Vac primary vaccination. However, the VE of both booster regimens against the Omicron variant was almost equal (64% in the homologous regimen and 57% in heterologous regimen). Hybrid immunity evidenced a better humoral response and a greater and longer protection against Delta and Omicron infections compared to vaccination-induced immunity in COVID-19-naïve individuals. Finally, the findings show that VE waned with time during the same wave, highlighting the importance of reinforcing primary and booster COVID-19 vaccination mainly at the beginning of each wave during the surge of a new variant of concern.
Collapse
Affiliation(s)
- Rima Moghnieh
- Division of Infectious Diseases, Department of Internal Medicine, Makassed General Hospital, Beirut P.O. Box 11-6301, Lebanon
- Faculty of Medicine, Lebanese University, Beirut P.O. Box 6573/14, Lebanon
| | - Claude El Hajj
- Faculty of Medicine, Lebanese University, Beirut P.O. Box 6573/14, Lebanon
- Middle East Airlines-AIRLIBAN S.A.L., Beirut P.O. Box 206, Lebanon
| | - Dania Abdallah
- Pharmacy Department, Makassed General Hospital, Beirut P.O. Box 11-6301, Lebanon
| | - Nayla Jbeily
- FMPS Holding S.A.L., Beirut P.O. Box 60 247, Lebanon
| | - Abdul Rahman Bizri
- Department of Internal Medicine, Division of Infectious Diseases, American University of Beirut Medical Center, Beirut P.O. Box 11-0236, Lebanon
| | - Mohamed H. Sayegh
- GAP Solutions under Contract No. 75N93019D00026 with National Institute of Allergy and Infectious Diseases, National Institutes of Health, Department of Health and Human Services, United States of America, Washington, DC 20201, USA
- Faculty of Medicine, American University of Beirut, Beirut P.O. Box 11-0236, Lebanon
| |
Collapse
|